WILL YOU HELP US REVOLUTIONISE PROSTATE CANCER DIAGNOSIS?
We all know that prostate cancer devastates lives. Every year, it kills 11,000 men in the UK and far more around the world. Those who live with prostate cancer often face invasive and damaging treatments, with side-effects including incontinence and impotence. But, for many of them, the treatment is completely unnecessary.
Because, surprisingly, most cases of prostate cancer are harmless.
Currently, men with raised PSA levels or those on active surveillance require regular invasive biopsies, yet there is no way for doctors to distinguish between aggressive, life-threatening ‘tiger’ cancers, and harmless cancers.
The result? Clinicians have to treat everyone. And, in the UK, that means putting approximately 17 men through devastating treatment they don’t need, for every one man whose life is actually at risk.
THE UEA PROSTATE CANCER TESTS
In a world first, UEA researchers, led by world-leading cancer geneticist Professor Colin Cooper, have unravelled the genetic information behind prostate cancer using complex maths and artificial intelligence. And after more than a decade of work, have developed two new tests for prostate cancer that could transform the lives of men around the world.
The Prostate Urine Risk (PUR) test uses urine samples to detect aggressive prostate cancers years before treatment is needed. It is non-invasive and can be carried out at home, reducing the need for regular biopsies.
The Tiger Test is a revolutionary new clinical test that can reliably distinguish aggressive prostate cancers from harmless ones. That means more men getting the treatment they need. And thousands spared from suffering needless side-effects.
The first phases of the research are complete. But they need the help of people like you to prove the tests in clinical trials and get them into the hands of clinicians and patients worldwide.
HOW YOU CAN HELP
Please donate now to help the UEA Prostate Cancer Tests begin saving lives. With your support, we can fund the clinical trials needed to have the tests adopted by the NHS and hospitals around the world.
If you’d like to find out more, or make a larger gift, contact the Development Office at email@example.com.
THE PIONEER PODCAST PROSTATE CANCER SPECIAL
We are kicking off our new podcast series with a three-part special on Prostate Cancer Research at UEA. This special feature will take an in-depth look at the science, the process and, most importantly, the team behind this revolutionary work.
Want to find out more before you dive in? Martin Tyler introduces the series in this short video